Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response.

Antunes KH, Fachi JL, de Paula R, da Silva EF, Pral LP, Dos Santos AÁ, Dias GBM, Vargas JE, Puga R, Mayer FQ, Maito F, Zárate-Bladés CR, Ajami NJ, Sant'Ana MR, Candreva T, Rodrigues HG, Schmiele M, Silva Clerici MTP, Proença-Modena JL, Vieira AT, Mackay CR, Mansur D, Caballero MT, Marzec J, Li J, Wang X, Bell D, Polack FP, Kleeberger SR, Stein RT, Vinolo MAR, de Souza APD. · 2019

Read Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. by Antunes KH, Fachi JL, de Paula R, da Silva EF, Pral LP, Dos Santos AÁ, Dias GBM, Vargas JE, Puga R, Mayer FQ, Maito F, Zárate-Bladés CR, Ajami NJ, Sant'Ana MR, Candreva T, Rodrigues HG, Schmiele M, Silva Clerici MTP, Proença-Modena JL, Vieira AT, Mackay CR, Mansur D, Caballero MT, Marzec J, Li J, Wang X, Bell D, Polack FP, Kleeberger SR, Stein RT, Vinolo MAR, de Souza APD. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6646332.txt.

Description

Antunes and co-authors show that a gut microbe product protects mice against RSV. Their study appears in Nature Communications. Severe RSV infection is a leading threat to infants. The team fed mice a high-fibre diet before infection. Those mice lost less weight and carried less virus. Lung inflammation also ran lower. The protection depended on gut microbes and acetate. Giving acetate alone reproduced the benefit.

Acetate switched on interferon-beta responses in the lung. It raised interferon-stimulated gene expression there. The receptor GPR43 on lung epithelial cells was required. Mice lacking GPR43 lost the protection entirely. Type 1 interferon signalling proved essential as well. The findings link diet, microbes, and antiviral defence.

Catalog record

CREATORAntunes KH, Fachi JL, de Paula R, da Silva EF, Pral LP, Dos Santos AÁ, Dias GBM, Vargas JE, Puga R, Mayer FQ, Maito F, Zárate-Bladés CR, Ajami NJ, Sant'Ana MR, Candreva T, Rodrigues HG, Schmiele M, Silva Clerici MTP, Proença-Modena JL, Vieira AT, Mackay CR, Mansur D, Caballero MT, Marzec J, Li J, Wang X, Bell D, Polack FP, Kleeberger SR, Stein RT, Vinolo MAR, de Souza APD.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE80 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6646332

Browse the full library · About the Tower of Babel